| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8707662 | Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology | 2018 | 18 Pages |
Abstract
Denosumab was associated with an earlier occurrence of MRONJ compared with zoledronate and pamidronate. The role of PMDE may be an effective preventive strategy in reducing the incidence of MRONJ.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Adepitan A. BChD, See Toh Yoong BDS, MDS, Adi Z. BS, Kant BA, SaeHee K. DDS, MPH, Joseph M. DDS, Cherry L. DMD,